Diabetes Medications
New Oral Drug Leads to Better A1C and Weight Loss
Research Shows Benefits of Tirzepatide for Type 1 Diabetes and Obesity
Afrezza Inhaled Insulin for Type 1 and Type 2 Diabetes
New Weight Loss Drug CagriSema Shows Impressive Results in Clinical Trials
Uncover phase 2 clinical trial results of CagriSema, a promising diabetes treatment showing improvements in A1C, weight loss, and time in range.
FDA Approves Merilog, A New Rapid-Acting Insulin
